To evaluate this potential impact on plaque progression, we treated cholesterol-fed mice doubly deficient in apolipoprotein E/apolipoprotein B100 with low doses of VEGF (2 μg/kg) or albumin.

The research team systematically assessed the impact of natto on atherosclerosis in a mouse model over time. The findings ...

Cardiovascular disease, atherosclerosis and blood lipids; Macular degeneration ... supplements and medications on cancer prevention and treatment both in a xenograft mouse model and in vitro; Diet ...